Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Wei Shu

Showing results (461-470 of 471) with videos related to

Pageof 48
Sort By:
BMC Medicine|September 19, 2024
Nine months of bedaquiline, linezolid, levofloxacin, clofazimine, and cycloserine chemotherapy for rifampicin/multidrug-resistant tuberculosis: a multicenter, randomized, open-label non-inferiority trial in ChinaYanhua Song, Wei Shu, Yi Pei, et al.
Free Radical Biology & Medicine|August 15, 2022
The bs-YHEDA peptide protects the brains of senile mice and thus recovers intelligence by reducing iron and free radicalsXiaodie Gao, Zhigang Wang, Lijun Xiong, et al.
Frontiers in Public Health|February 13, 2023
Effect of a modified regimen on drug-sensitive retreated pulmonary tuberculosis: A multicenter study in ChinaQiping Ge, Yan Ma, Lijie Zhang, et al.
Journal of Medicinal Chemistry|March 1, 2022
Discovery and Preclinical Pharmacology of INE963, a Potent and Fast-Acting Blood-Stage Antimalarial with a High Barrier to Resistance and Potential for Single-Dose Cures in Uncomplicated MalariaBenjamin R Taft, Fumiaki Yokokawa, Tom Kirrane, et al.
International Journal of Clinical Practice|August 23, 2023
Epidemiology and Association Rules Analysis for Pulmonary Tuberculosis Cases with Extrapulmonary Tuberculosis from Age and Gender Perspective: A Large-Scale Retrospective Multicenter Observational Study in ChinaWanli Kang, Jiajia Yu, Chen Liang, et al.
Plos One|August 22, 2020
The epidemiology of extrapulmonary tuberculosis in China: A large-scale multi-center observational studyWanli Kang, Jiajia Yu, Jian Du, et al.
International Journal of Infectious Diseases : IJID : Official Publication of the International Society for Infectious Diseases|November 15, 2021
Epidemiology of concurrent extrapulmonary tuberculosis in inpatients with extrapulmonary tuberculosis lesions in China: a large-scale observational multi-centre investigationWanli Kang, Shengsheng Liu, Jian Du, et al.
Infectious Diseases of Poverty|March 19, 2021
Bedaquiline-containing regimens in patients with pulmonary multidrug-resistant tuberculosis in China: focus on the safetyJing-Tao Gao, Juan Du, Gui-Hui Wu, et al.
European Journal of Clinical Microbiology & Infectious Diseases : Official Publication of the European Society of Clinical Microbiology|October 23, 2020
The prevalence and risks of major comorbidities among inpatients with pulmonary tuberculosis in China from a gender and age perspective: a large-scale multicenter observational studyWanli Kang, Jian Du, Song Yang, et al.
Journal of Medicinal Chemistry|April 30, 2021
Discovery and Optimization of DNA Gyrase and Topoisomerase IV Inhibitors with Potent Activity against Fluoroquinolone-Resistant Gram-Positive BacteriaGuillaume Lapointe, Colin K Skepper, Lauren M Holder, et al.
Pageof 48

Showing results (461-470 of 471) with videos related to

Sort By:
Pageof 48
BMC Medicine|September 19, 2024
Nine months of bedaquiline, linezolid, levofloxacin, clofazimine, and cycloserine chemotherapy for rifampicin/multidrug-resistant tuberculosis: a multicenter, randomized, open-label non-inferiority trial in ChinaYanhua Song, Wei Shu, Yi Pei, et al.
Free Radical Biology & Medicine|August 15, 2022
The bs-YHEDA peptide protects the brains of senile mice and thus recovers intelligence by reducing iron and free radicalsXiaodie Gao, Zhigang Wang, Lijun Xiong, et al.
Frontiers in Public Health|February 13, 2023
Effect of a modified regimen on drug-sensitive retreated pulmonary tuberculosis: A multicenter study in ChinaQiping Ge, Yan Ma, Lijie Zhang, et al.
Journal of Medicinal Chemistry|March 1, 2022
Discovery and Preclinical Pharmacology of INE963, a Potent and Fast-Acting Blood-Stage Antimalarial with a High Barrier to Resistance and Potential for Single-Dose Cures in Uncomplicated MalariaBenjamin R Taft, Fumiaki Yokokawa, Tom Kirrane, et al.
International Journal of Clinical Practice|August 23, 2023
Epidemiology and Association Rules Analysis for Pulmonary Tuberculosis Cases with Extrapulmonary Tuberculosis from Age and Gender Perspective: A Large-Scale Retrospective Multicenter Observational Study in ChinaWanli Kang, Jiajia Yu, Chen Liang, et al.
Plos One|August 22, 2020
The epidemiology of extrapulmonary tuberculosis in China: A large-scale multi-center observational studyWanli Kang, Jiajia Yu, Jian Du, et al.
International Journal of Infectious Diseases : IJID : Official Publication of the International Society for Infectious Diseases|November 15, 2021
Epidemiology of concurrent extrapulmonary tuberculosis in inpatients with extrapulmonary tuberculosis lesions in China: a large-scale observational multi-centre investigationWanli Kang, Shengsheng Liu, Jian Du, et al.
Infectious Diseases of Poverty|March 19, 2021
Bedaquiline-containing regimens in patients with pulmonary multidrug-resistant tuberculosis in China: focus on the safetyJing-Tao Gao, Juan Du, Gui-Hui Wu, et al.
European Journal of Clinical Microbiology & Infectious Diseases : Official Publication of the European Society of Clinical Microbiology|October 23, 2020
The prevalence and risks of major comorbidities among inpatients with pulmonary tuberculosis in China from a gender and age perspective: a large-scale multicenter observational studyWanli Kang, Jian Du, Song Yang, et al.
Journal of Medicinal Chemistry|April 30, 2021
Discovery and Optimization of DNA Gyrase and Topoisomerase IV Inhibitors with Potent Activity against Fluoroquinolone-Resistant Gram-Positive BacteriaGuillaume Lapointe, Colin K Skepper, Lauren M Holder, et al.
Pageof 48